Ardian has bought a majority stake in Italy-based drugs producer Neopharmed Gentili from its parent company Mediolanum Farmaceutici, which is controlled by the Del Bono family.
GP invests in the software company via Essling Expansion, a fund that recently held a first close
BVA expects to become one of the main market research groups in Europe and reach revenues of €200m
GP sold Ober Scharrer to Nordic last year, generating a 3.6x return on its original investment
NIBC and existing investors including Prime also took part in the round for the SME lender